No Data
Morgan Stanley maintains a "Shareholding" rating on HANSOH PHARMA, with the Target Price raised to 25 Hong Kong dollars.
Morgan Stanley released a Research Report stating that it maintains a "Shareholding" rating for HANSOH PHARMA (03692), with the Target Price increased from the previous 24 Hong Kong dollars to 25 Hong Kong dollars. The company’s performance last year met expectations, but the upward revision of the peak sales guidance for Ameile along with this year’s sales guidance brings surprises. The peak sales of Ameile have been further raised from 6 billion yuan to 8 billion yuan, and a sales target of 6 billion yuan is set for this year, indicating that the previous estimates from the bank had upside potential, and this year’s growth will accelerate. The bank also stated that management expects product sales to achieve double-digit growth this year, with Innovative Drugs expected to grow by 25%. The company also...
Morgan Stanley: Believes there is a 70-80% chance that ZTO EXPRESS-W's stock price will rise in the next 60 days, maintaining a "Shareholding" rating.
Morgan Stanley issued a Research Report stating that ZTO EXPRESS-W (02057) is likely to accelerate its Share Buyback in the first half of 2025, leading to a shift in market expectations for shareholder returns in 2025. If ZTO EXPRESS resumes its Share Buyback, Morgan Stanley will view it as a potential catalyst for stock prices, predicting that this scenario could occur within the next 60 days with a probability of about 70% to 80%, and will maintain a 'Shareholding' rating.
Macquarie Keeps Bull Despite Soft Capital Markets -- Market Talk
The chief investment officer of Morgan Stanley predicts that U.S. stocks may reach new highs in the second half of the year, with the S&P 500 Index potentially reaching 6,500 points by year-end.
Mike Wilson, Chief Investment Officer at Morgan Stanley, believes investors will return en masse to the USA Stocks market, and the recently hard-hit 'Magnificent Seven' Stocks will once again become winners. In an interview on Monday, Wilson stated: 'Initially, it was a low-quality rebound, which we anticipated - this indicates a short-term squeeze. Then, what we noticed is that the correction factor of the Magnificent Seven has actually begun to stabilize. Therefore, the market has shown some improvement over the past few days, which could drive the Index higher. How high? 5,900 points.'
Market Chatter: Morgan Stanley Leads Financing of Clearlake's Bid to Take Dun & Bradstreet Private
Shares of Financial Stocks Are Trading Higher Amid Overall Market Strength on Reports of Potentially Narrowed or Targeted Tariffs, Which May Be Easing Investor Concerns.
Deranged Soul 420 : lol was able to give you another like on YouTube?!